The neurosurgical treatment of patients in dystonic state – Overview of the literature by Sobstyl, Michał Roman et al.
Review article
The neurosurgical treatment of patients in dystonic
state – Overview of the literature
Michał Roman Sobstyl a,*, Jarosław Wojciech Sławek b, Mirosław Ząbek a
aDepartment of Neurosurgery, Postgraduate Medical Center, Warsaw, Poland
bDepartment of Neurological-Psychiatric Nursing and Department of Neurology, Medical University of Gdansk and St. Adalbert Hospital,
Gdansk, Poland
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 6 3 – 7 0
a r t i c l e i n f o
Article history:
Received 9 December 2012
Accepted 17 April 2013
Available online 23 January 2014
Keywords:
Status dystonicus
Thalamotomy
Pallidotomy
Deep brain stimulation
Pallidal stimulation
a b s t r a c t
Treatment options for patients in dystonic state include sedation, artiﬁcial ventilation,
intrathecal baclofen infusions and stereotactic procedures. The main aim of this overview is
the presentation and assessment of stereotactic procedures applied for treating patients in
severe dystonic state. We performed literature overview starting from 1998 to 2012 with case
reports regarding all patients treated by stereotactic procedures for dystonic state. We were
able to ﬁnd 15 articles describing 22 patients. Ablative procedures were described in 5 articles
(3 thalamotomies, 3 pallidotomies) and were done in 6 patients. In the remaining 10 articles,
globus pallidus internus stimulation was utilized in another 16 patients. We can conclude
that bilateral pallidal deep brain stimulation seems to be the best stereotactic target for
patients in dystonic state.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Status dystonicus (SD), also known as dystonic storm, is a
sudden and persistent episode characterized by acute wors-
ening of dystonic movements, usually affecting patients with
an established diagnosis of primary or secondary generalized
dystonia. In view of its associated complications, status
dystonicus is regarded as a life-threatening condition. There
are several types of secondary dystonia which may be
complicated by SD, including post-traumatic and post-inﬂam-
matory dystonia, and rapid exacerbation of dystonic move-
ments in patients suffering from cerebral palsy. Certain
neurodegenerative diseases such as Wilson disease or* Corresponding author at: Klinika Neurochirurgii, Centrum Medyczn
Poland.
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http://dx.doi.org/10.1016/j.pjnns.2013.04.002neurodegeneration with brain iron accumulation (NBIA,
formerly called Hallervorden–Spatz syndrome) may also
precipitate status dystonicus [1]. Trigger factors for SD
typically include febrile infections, dehydration, dyselectroly-
taemia, administration of medications (e.g. penicillamine in
Wilson disease) and sudden discontinuation of drugs (e.g.
anticholinergics, tetrabenazine, intrathecal baclofen or lithi-
um).
Clinical symptoms of status dystonicus were ﬁrst described
by Jankovic and Penn in 1982 [2]. The ﬁrst reported case was
that of an 8-year-old boy with primary generalized dystonia
whose neurological condition deteriorated signiﬁcantly over a
period of six months. The patient required sedation, paralysis
and mechanical ventilation. Dystonic storm was managedego Kształcenia Podyplomowego, ul. Marymoncka 99, Warszawa,
blished by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Marsden et al. [3] described two other patients with primary
generalized dystonia who presented with a sudden-onset
worsening of the disease. The condition of the patients was
deﬁned as ‘‘desperate dystonics’’. One of the patients, a 12-
year-old boy, required sedation, paralysis and mechanical
ventilation for two weeks. Pharmacological treatment intro-
duced by the author (benzhexol, pimozide and tetrabenazine)
proved effective and resulted in an improvement of symp-
toms. The other patient, a 15-year-old boy with dysphagia and
frequent episodes of painful generalized dystonic spasms,
however, failed to respond to the same pharmacological
regimen. Pimozide was even found to increase the symptoms
of dystonia in that patient [3]. Another case of effectively
managed SD was reported by Narayan et al. [4] in 1991. It was a
case of an 18-year-old man with predominantly axial dystonia
caused by perinatal injury. The patient's condition deteriorat-
ed after spinal surgery, when opisthotonus and dystonic
spasms of the lower extremities, abdominal and respiratory
muscles were observed. The patient required sedation and
mechanical ventilation. Pharmacological therapy with anti-
cholinergic agents, tetrabenazine and oral baclofen was
ineffective. In order to alleviate excessive muscle rigidity,
the authors used an intrathecal infusion of baclofen which
helped to achieve a nearly complete control of dystonia.
Another report, authored by Vaamonde et al. [5], focused on
two cases of status dystonicus in children. The authors were
the ﬁrst to apply the term ‘‘dystonic storm’’ to refer to the
observed symptoms. One of the patients suffered from
primary generalized dystonia and the other from NBIA. Both
had to be sedated and mechanically ventilated. Pharmacolog-
ical treatment was introduced; however, it proved ineffective
in the patient with primary dystonia, while the second patient,
who had presented with secondary dystonia, responded only
to oral baclofen.
The historical overview presented above encompasses
descriptions of isolated cases of SD. Subsequent years saw the
publication of a few reports on a series of cases. The ﬁrst
authors to describe, in 1998, a group of 12 patients with SD
episodes were Manji et al. [1]. The authors reviewed cases of
SD covering a nearly 10-year period, and were the ﬁrst to
report on thalamotomies performed in SD patients. In one
patient, bilateral thalamotomy brought no therapeutic effect.
In another patient, who suffered from hemidystonia, howev-
er, the procedure contributed to a regression of SD. The largest
group of patients with SD episodes was reviewed by Fasano
et al. [6] in a retrospective multi-centre study covering a total
of 89 episodes of SD which occurred in 68 patients over a span
of nearly 18 years. The authors conclude that surgical
treatment (globus pallidus stimulation) has proven to be
superior to all other therapeutic modalities available for SD
episodes.
Although SD is a rare complication of dystonia, it is a
life-threatening condition. An appropriate diagnosis and
rapid management are thus vital for patient survival.
Current effective treatment modalities for SD include
stereotactic implantation of electrodes in the internal
globus pallidus. Paradoxically, however, sudden interrup-
tion of neurostimulation may also result in the development
of SD.2. Conservative (pharmacological)
management of status dystonicus
Pharmacological treatment of primary and secondary dysto-
nias remains an empiric therapy. The prevailing opinion is
that the treatment of choice in children suffering from
dystonia is based on levodopa. In dopa-responsive dystonia
(DRD), the treatment results in complete regression of
symptoms [1]. In order to conﬁrm or rule out DRD, a
therapeutic trial of levodopa should always be considered in
SD patients. This type of dystonia is commonly diagnosed
during childhood, between 4 and 8 years of age. Second-line
treatment of paediatric dystonia is based on anticholinergic
agents, the most common being benzhexol [8]. For severe
dystonia episodes, Marsden et al. [3] suggest concurrent
combined therapy with tetrabenazine, pimozide and benz-
hexol to achieve symptomatic relief. Some authors claim that
more effective pharmacological therapies are based on
baclofen, levodopa preparations and antiepileptics including
carbamazepine [5].
Status dystonicus treatment should be conducted in the
intensive care unit setting due to the risk of life-threatening
complications and failure of attempted pharmacological
therapies. The most serious immediate threat to the life of
SD patients is respiratory failure triggered by the excessive
contraction of muscles of the upper respiratory tract, chest and
abdomen [1,7]. Status dystonicus patients are under the risk of
developing dysphagia and aspiration caused by spasmodic
action of the muscles of the throat and oesophagus which may
lead to aspiration pneumonia [9]. Frequently, the symptoms
listed above induce hypoventilation followed by hypoxaemia.
This is also an immediately life-threatening condition requir-
ing muscle paralysis, sedation, intubation and mechanical
ventilation [1]. A major adverse complication is rhabdomyoly-
sis (elevated levels of creatine kinase in blood serum) resulting
from the breakdown or disintegration of striated muscles
during their increased activity [1,2]. An early clinical sign of the
condition may be discoloured (tea-coloured) urine. Rhabdo-
myolysis leads to sudden renal failure accompanied by anuria.
In most instances, renal failure is transient with the eventual
return of normal renal function; some patients, however,
require temporary renal replacement therapy.
Exhaustion observed in SD patients as a result of prolonged
severe dystonia and pain caused by dystonic spasms is
recognized as an indication for performing sedation and
muscle paralysis. Sedation and mechanical ventilation should
be continued for 4–6 days. As the next stage, doses of sedatives
and muscle relaxants are gradually reduced to assess the
severity of SD. Effective control of SD symptoms over
consecutive days can only be achieved with a sedative agent
such as propofol. On account of its pharmacokinetic proper-
ties, the drug allows a quick assessment of the patient's
consciousness and neurological status upon its discontinua-
tion. Another drug routinely used for the sedation of SD
patients is midazolam. As opposed to propofol, midazolam
exhibits a slightly more pronounced sedative effect on the
cardiovascular system. It also has a markedly longer half-life,
which may occasionally interfere with the assessment of the
patient's consciousness status [10,11].
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and pallidotomy) in the treatment of status
dystonicus
In the past, stereotactic treatment was introduced in those SD
patients who underwent sedation, muscle paralysis and
mechanical ventilation, and experienced a recurrence of
status dystonicus upon gradual discontinuation of sedatives
and muscle relaxants. At the time, the stereotactic target of
choice for the treatment of dystonia was the area of
ventrolateral thalamic nuclei. Cooper [12] found thalamotomy
to be the most effective method of treatment in patients with
primary or secondary generalized dystonia. A 70% reduction of
dystonia symptoms was achieved in the study conducted by
this author. Cooper's excellent results, however, were not
conﬁrmed by ﬁndings obtained by Andrew et al. [13]. The
authors noted only a 25% reduction of symptoms of primary or
secondary generalized dystonia following thalamotomy [13].
Bilateral thalamotomy was associated with a very high risk of
persistent postoperative dysarthria and dysphagia [13]. Tha-
lamotomy was the ﬁrst stereotactic surgery used in the
treatment of patients with SD that was refractory to standard
drug therapy [1]. In subsequent years, pallidotomy was found
to be an effective modality in the treatment of drug-induced
dyskinesia in patients with advanced Parkinson disease [14].
Consequently, the main target of stereotactic surgery shifted
from the thalamus to the internal globus pallidus (GPi). The
next stage in the development of functional neurosurgery for
dystonia was the application of bilateral GPi stimulation for
the treatment of primary generalized dystonia and then drug-
refractory SD [15].
As mentioned previously, the ﬁrst report of thalamotomy
performed in two SD patients was published by Manji et al. [1].
Two-stage thalamotomy carried out in a 9-year-old boy with a
history of dystonia and athetoid movements secondary to
perinatal injury caused by premature birth failed to improve
the patient's neurological status. A marked improvement
following unilateral thalamotomy, however, was noted by the
authors in a 38-year-old woman with right-sided post-
encephalitic hemidystonia [1]. In addition to an improvement
observed on the patient's right side, stereotactic left thala-
motomy also improved the patient's dystonic position of the
left upper limb. Another case of therapeutic beneﬁt achieved
with pallidotomy was reported by Justesen et al. [16] in a 10-
year-old patient with NBIA and dystonia causing respiratory
disability [16]. Unilateral (left-sided) pallidotomy brought
about a regression of dystonic movements of the right side,
and restoration of normal respiratory function. The effect
proved to be long-lasting [16]. A similar beneﬁt was achieved in
the same indication by other authors following bilateral
pallidotomy [17,18]. In a report of ﬁve cases of patients with
SD episode, Teive et al. [18] describe bilateral pallidotomy in a
patient suffering from cerebral palsy and generalized dystonia.
The patient also had epilepsy. Bilateral pallidotomy combined
with antiepileptic treatment, biperiden and clonazepam
turned out to be an effective modality for controlling dystonic
movements.
The cases of surgical treatment of SD outlined above
support the efﬁcacy of ablative operations (Table 1). Themajority of patients underwent bilateral surgeries due to
generalized severity of dystonic movements [16,18,19]. In
some of the cases, unilateral stereotactic surgery was shown to
be a therapeutic modality providing effective control of
contralateral dystonic movements, contributing to a relief of
SD symptoms [17,20]. Given limited experience, it is difﬁcult to
determine the preferred target for stereotactic surgery in SD
treatment. Pallidotomy is more effective for SD management
than thalamotomy, which stems principally from neuroana-
tomical considerations. Interestingly, the authors observed no
complications of bilateral pallidotomies in the majority of
children who underwent surgery due to primary generalized
dystonia or SD [21]. Such complications – including dysarthria,
dysphagia, sensory disorders and paresis – were reported in
some patients following two-stage bilateral thalamotomy [13].
Furthermore, thalamotomy only involves the disruption of
thalamocortical connections, without affecting pallidal ﬁbres
running from the main input structure for main output
structure of the extrapyramidal system, i.e. the sensorimotor
area of GPi which has a decisive effect on the pyramidal system
[22]. In addition to blocking pallidal ﬁbres which extend to the
thalamus, and thalamocortical connections, pallidotomy also
blocks pallidal and brainstem ﬁbres running to the peduncu-
lopontine nucleus which, as one of its primary functions,
controls axial and proximal striated muscles via the descend-
ing reticulospinal tract. The muscles are very often involved in
dystonic movements in patients suffering from different
primary and secondary generalized dystonic syndromes. This
explains the efﬁcacy of pallidotomy or GPi stimulation in the
treatment of dystonia involving axial muscles. A very
interesting observation concerns bilateral reduction of hyper-
kinetic movements as a result of unilateral pallidotomy. The
effect is markedly less common following unilateral thala-
motomy [13,20]. It is determined by the presence of numerous
pallidal ﬁbres which extend not only to the ipsilateral thalamic
nuclei including the complex of ventrolateral anterior and
ventrolateral nuclei but also to the centromedian thalamic
nucleus [21]. Neuroanatomical studies have demonstrated
that 10–20% of all pallidal ﬁbres transgress the median line in
the posterior section of the centromedian thalamic nucleus
and, via the supracommisural decussation, extend to the same
thalamic nuclei as ipsilateral ﬁbres [21]. In addition, pallidal
and brainstem ﬁbres innervate both ipsi- and contralateral
pedunculopontine nuclei, i.e. bilateral motor regions of the
brainstem. GPi, with its numerous connections to the thalamic
nuclei and areas controlling brainstem motor function, is thus
the stereotactic target of choice for the management of
patients with dystonia and SD.
4. Deep brain stimulation in the treatment of
status dystonicus
Similarly to ablative surgical methods, the number of SD
patients treated with GPi stimulation continues to be limited.
A review of international medical literature, however, reveals
a growing number of reports on isolated cases or small groups
of patients treated with GPi stimulation. Factors that have
contributed to the wider use of GPi stimulation include
increased availability of this neuromodulatory technique
Table 1 – Outcome of ablative procedures (thalamotomy, pallidotomy) in patients with status dystonicus. This table includes the information regarding aetiology of dystonia,
coexistence of other involuntary movements, and triggering factors if identified. This table includes also data regarding first dystonic symptoms, age at surgery, results and
follow-up time in each case described in the manuscript.
Authors and year
of publication
Aetiology of dystonia and
coexisting involuntary
movements
Factor triggering
status
dystonicus
Age at the
onset of
dystonia
[years]
Age at the time
of stereotactic
surgery [years]
Stereotactic
target
Outcome of the
surgery
Follow-up period
(in months or
years)
Manji et al. (1998) [1]
Patient 1
Cerebral palsy followed by
meningitis. Coexisting athetoid
movements.
Probably a
bacterial infection
2 13 Vim and Vop
thalamic nuclei.
Two-stage bilateral
thalamotomy.
Poor 5 months – death of
the patient
Manji et al. (1998) [1]
Patient 2
Right-sided post-encephalitic
hemidystonia
Probably a viral
infection
17 38 Ventrolateral
complex of
thalamic
nuclei – left-sided
thalamotomy
Very good – bilateral
effect
24 months
Justesen et al. (1999) [16] Neurodegeneration with
brain iron accumulation
The trigger of the
SD episode
has not been
identiﬁed
6 10 Left-sided
pallidotomy
Good 6 months
Kyriagis et al. (2004) [17] Neurodegeneration with
brain iron accumulation
The trigger of the
SD episode
has not been
identiﬁed
Between 7 and 8 9 Bilateral
pallidotomy
Good effect until 6
months of follow-up,
then deterioration
15 months – death due
to massive pneumonia
Teive et al. (2005) [18] Dystonia secondary to
cerebral palsy and epilepsy
The trigger of the
SD episode
has not been
identiﬁed
No data available 8 Bilateral
pallidotomy
Very good effect Unknown
Balas et al. (2006) [19] Neurodegeneration with
brain iron accumulation
The trigger of the
SD episode
has not been
identiﬁed
5 10 Ventrolateral
complex of
thalamic nuclei
and ventrolateral
posterior area of
internal globus
pallidus
Very good effect 48 months
Elkay et al. (2009) [28]
Patient 1
Dystonia due to Batten's
disease
The trigger of the
SD episode
has not been
identiﬁed
5 17 Bilateral
pallidotomy
Good 72 months
Vim – nucleus ventralis indermedius thalami; Vop –nucleus ventralis oralis posterior; SD – status dystonicus (dystonic state).
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primary or secondary generalized dystonias.
One of the ﬁrst reports on successful SD treatment with
bilateral GPi stimulation was presented by Angelini et al. [23] in
a 13-year-old boy with a dystonia-dyskinesia syndrome. The
aetiology of dystonia could not be determined. Most probably,
the condition resulted from the patient's birth injury and his
speciﬁc form of cerebral palsy. Bilateral GPi stimulation proved
to be an effective method to control dystonic movements.
Similar efﬁcacy of bilateral GPi stimulation was reported by
Zorzi et al. in three SD patients. The authors achieved an
outstanding neurological improvement in two patients with
DYT1-negative primary dystonia. In one patient with SD
secondary to encephalopathy of unknown origin the improve-
ment was, however, limited [24]. Teive et al. applied bilateral
GPi stimulation to a 57-year-old female patient with cranial-
cervical dystonia who had been treated with botulinum toxin
injections for many years. The patient developed SD in
reaction to a stress factor. Bilateral GPi stimulation brought
about a total regression of dystonia [18].
The efﬁcacy of GPi stimulation for the management of SD
secondary to NBIA was conﬁrmed by reports authored by
Mariotii et al. [10] and Grandas et al. [25]. Very high efﬁcacy of
bilateral GPi stimulation in the treatment of primary general-
ized dystonia without DYT-1 mutation was also reported by
Jech et al. [26]. Bilateral implantation of electrodes in the
internal globus pallidus in a 12-year-old boy resulted in a
complete regression of SD [26]. One of the factors potentially
triggering SD is an abrupt change in drug therapy, while
dystonia can be a consequence of prolonged treatment with
antipsychotic agents, particularly antagonists of dopamine
receptors. The drugs, which are usually taken on a long-term
basis, may lead to a range of motor disorders including
dystonia, Parkinson disease and akathisia. SD induced by
antipsychotic drugs is a rare phenomenon. One such case was
reported by Kovacs et al. [27]. Prolonged use of risperidone
combined with clonazepam led to segmental dystonia which
escalated into SD. Bilateral GPi stimulation contributed to a
total regression of dystonia.
A very interesting report on the application of a combined
neurosurgical modality comprising pallidotomy and bilateral
GPi stimulation for the treatment of SD due to Batten's disease
was presented by Elkay et al. [28]. The authors argue that
combined neurosurgical treatment remains an effective
method of treatment of hyperkinetic movements leading to
SD in paediatric patients with Batten's disease. It improved the
quality of life of patients and allowed their return to normal
life. What is more, pallidotomy or GPi stimulation makes it
possible to gradually discontinue sedative drugs, and contrib-
utes to the subsidence of painful muscle spasms and
symptoms of generalized dystonia [28].
A report on the cases of two patients with dystonic cerebral
palsy and coexisting choreoathetosis, who developed status
dystonicus after undergoing general anaesthesia, was pub-
lished by Apetauerova et al. [29]. A follow-up period of several
months demonstrated that bilateral GPi stimulation had
produced an immediate resolution of SD in both cases. In
the latest report, dating from 2012, Walcott et al. [30] discuss
cases of three children with status dystonicus resulting from
various dystonic syndromes that were treated with bilateralGPi stimulation. The technique proved to be the most effective
method of SD treatment. All studies investigating GPi
stimulation in SD treatment are listed in chronological order
in Table 2.
One of the most important aspects that must be addressed
when considering implantation of a deep brain stimulation
system in children is their continued growth. Steady brain
growth in paediatric patients may cause dislocation of the
electrode, which is associated with an elevated risk of a
gradual loss of stimulation efﬁcacy. None of the studies
outlined above mentions the problem, probably because the
majority of surgically treated SD patients were over 12 years
old and only 4 patients underwent an operation before 10
years of age. The youngest surgically treated patient was 8
years old [24,30]. Furthermore, postoperative follow-up
period among the youngest patients treated with bilateral
brain stimulation varied from 3 months to 19 months. Thus, it
was impossible for the intracranial electrode to become
dislocated as a result of brain growth over such a short
follow-up period [24,30]. The potential problem can be
resolved by changing active contacts of the electrode
implanted in the brain. When GPi is the stereotactic target,
the distance between the active contacts of the electrode is
1.5 mm. By stimulating proximal contacts, it is possible to
compensate for possible dislocation of the electrode in the
brain caused by children's growth. If, however, the effect of
stimulation and the possibility of managing dystonia by
changing active contacts become signiﬁcantly compromised,
the solution to consider is the implantation of another
electrode. The method was applied by French neurosurgeons
in patients with generalized dystonias in whom the thera-
peutic effect of GPi neurostimulation had become reduced.
The implantation of another electrode caused further
improvement of the patients' clinical condition [31]. Another
possible approach is to move the initially implanted
electrode upwards in the stereotactic setting under ﬂuoro-
scopic control. The technique, however, is associated with an
increased risk of intracranial bleeding. Children's physiolog-
ical growth is also a factor potentially leading to a higher risk
of mechanical damage to the deep brain stimulation system
in children. Currently available deep brain stimulation
systems are more ﬂexible and elastic, which, however, does
not completely rule out the possibility of mechanical
disruption caused by brain growth. American authors who
applied the method of brain stimulation in children described
the complication as quite rare: it was noted in just two cases
(one case of intracranial electrode break and one of damage to
the extension) in the initial study group of 31 children. The
mean age of the patients at the time of surgery was 13.2 years,
and varied from 4 to 17 years. The most common complica-
tions observed by the authors were infections, especially in
the youngest patients. In order to reduce the risk of infection,
mechanical damage or skin erosions developing above the
implant, the majority of procedures in children involve
placement of the pulse generator in the abdomen [30,32].
Implantation of the pulse generator subcutaneously below
the clavicle is not recommended because the device is
relatively large which, coupled with the thinness of the
subcutaneous fatty tissue, makes the site prone to erosions
and infections [24,30].
Table 2 – Outcome of deep brain stimulation – bilateral pallidal stimulation in patients in dystonic state. The information included in this table describes the same data like
in Table 1.
Authors and year
of publication
Aetiology of
dystonia and
coexisting
involuntary
movements
Factor triggering status
dystonicus
Age at the
onset of
dystonia
[years]
Age at the time
of stereotactic
surgery [years]
Stereotactic
target
Outcome
of the
surgery
Follow-up
period (in months
or years)
Angelini et al. (2000) [23] Cerebral palsy The trigger of the SD episode
has not been identiﬁed
8 months 13 Bilateral
GPi stimulation
Very good 7 months
Zorzi et al. (2005) [24]
Patient 1
Primary generalized
non-DYT-1 dystonia
The trigger of the SD episode
has not been identiﬁed
1.6 8.2 Bilateral
GPi stimulation
Very good 15 months
Patient 2 Encephalopathy of
unknown origin
Upper respiratory tract
infection
6 months 14.2 Bilateral
GPi stimulation
Slight 15 months
Patient 3 Primary generalized
non-DYT-1 dystonia
The trigger of the SD episode
has not been identiﬁed
3 10.6 Bilateral
GPi stimulation
Very good 19 months
Teive et al. (2005) [18] Craniocervical dystonia Stress factor Long history
of dystonia
57 Bilateral
GPi stimulation
Very good
effect
Unknown
Mariotii et al. (2007) [10] Neurodegeneration with
brain iron accumulation
(PANK2)
Upper respiratory and
urinary tract infections
7 15 Bilateral
GPi stimulation
Good 12 months
Elkay et al. (2009) [28]
Patient 2
Dystonia due to Batten's
disease
The trigger of the SD episode
has not been identiﬁed
2 19 Bilateral
pallidotomy +
bilateral
GPi stimulation
Good 7 months
Jech et al. (2009) [26] Primary generalized
dystonia
The trigger of the SD episode
has not been identiﬁed
8 12 Bilateral
GPi stimulation
Good 15 months
Apeetauerova et al.
(2010) [29]
Patient 1
Cerebral palsy General anaesthesia +
metoclopramide
16 16 Bilateral
GPi stimulation
Very good 30 months
Patient 2 Cerebral palsy General anaesthesia 26 26 Bilateral
GPi stimulation
Very good 34 months
Grandas et al. (2011) [25] Neurodegeneration with
brain iron accumulation
(PANK2)
The trigger of the SD episode
has not been identiﬁed
17 19 Bilateral
GPi stimulation
Very good 9 months
Kovacs et al. (2011) [27] Drug-induced
dystonia
Antipsychotic drugs 18 18 Bilateral
GPi stimulation
Very good 12 months
Walcott et al. (2012) [30]
Patient 1
Neonatal jaundice,
encephalopathy,
cerebral palsy
Spinal surgery followed by
infection of surgical wound
Long history 14 Bilateral
GPi stimulation
Very good 12 months
Patient 2 Primary generalized
dystonia
The trigger of the SD episode
has not been identiﬁed.
4 months' history 9 Unilateral
GPi stimulation
Good 2 months
Patient 3 Cerebral
palsy, spastic
quadriparesis
Probably an upper
respiratory tract infection
Exacerbation of
dystonia over
preceding two
months
9 Bilateral
GPi stimulation
Good 3 months
SD – status dystonicus (dystonic state); GPi – internal globus pallidus.
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mention of the treatment of SD in any patient suffering from
generalized dystonia. Polish publications on GPi stimulation in
the management of dystonia conﬁrm that the method has
been both effective and safe for the treatment of diverse motor
disorders including advanced Parkinson disease over the past
several years [33–35].
5. Summary
The cases of surgical treatment of SD presented above show
that ablative operations and GPi stimulation are effective
therapeutic modalities. Status dystonicus always requires
combined treatment, whereas stereotactic surgery is regarded
as the method of last choice for SD. Neurosurgical treatment is
beneﬁcial in that it eliminates the need for using sedative
drugs and successfully alleviates symptoms accompanying
primary or secondary generalized dystonias. Nearly 60% of SD
cases occur in children below 15 years of age. The therapeutic
method of choice remains bilateral GPi stimulation. What is
more, the method can be successfully applied in patients who
have previously had ablative surgery (either thalamotomy or
pallidotomy), as shown in medical reports. Neurosurgery is not
only a highly effective form of SD treatment but also
prevention: no SD recurrence has been observed in patients
with a history of neurosurgical procedure.
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